Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.81
-0.44 (-3.32%)
At close: Apr 28, 2026, 4:00 PM EDT
13.06
+0.25 (1.95%)
After-hours: Apr 28, 2026, 5:48 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $775.34 million as of April 28, 2026. Its market cap has increased by 74.81% in one year.
Market Cap
775.34M
Enterprise Value
400.73M
1-Year Change
74.81%
Ranking
Category
Stock Price
$12.81
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $775.34M, a decrease of -6.52%. That is a compound annual growth rate of -1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 801.97M | 31.16% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 826.74M |
| Arbutus Biopharma | 819.27M |
| Kura Oncology | 792.65M |
| Design Therapeutics | 790.02M |
| Vor Biopharma | 785.15M |
| ARS Pharmaceuticals | 781.97M |
| SpyGlass Pharma | 767.58M |
| Allogene Therapeutics | 765.35M |